One-year retention of gait speed improvement in stroke survivors after treatment with a wearable home-use gait device.

Background: Gait impairments after stroke are associated with numerous physical and psychological consequences. Treatment with the iStride gait device has been shown to facilitate improvements to gait function, including gait speed, for chronic stroke survivors with hemiparesis. This study examines the long-term gait speed changes up to 12 months after treatment with the gait device.

Gait Device Treatment Using Telehealth for Individuals With Stroke During the COVID-19 Pandemic: Nonrandomized Pilot Feasibility Study.

Background: During the COVID-19 pandemic, rehabilitation providers and consumers adopted telehealth practices at unprecedented rates. Multiple prepandemic studies demonstrate the feasibility and comparable efficacy between in-clinic and remote treatment for certain impairments caused by stroke, such as upper extremity weakness and impaired motor function. However, less guidance has been available regarding gait assessment and treatment.

Wearable gait device for stroke gait rehabilitation at home.

Background: Hemiparesis is a common disabling consequence of stroke that leads to abnormal gait patterns marked by asymmetries in step length, stance, and swing phases. Asymmetric gait patterns are correlated with decreased gait velocity and increased susceptibility to falls that can lead to serious injuries and hospitalizations.

Objective: In this single group, before and after study, treatment with the iStride gait device, designed to improve the gait patterns of individuals with hemiparesis, is adapted to the home environment.